Search
Pantothenic acid
go.drugbank.com/drugs/DB01783ApprovedInvestigationalNutraceuticalVet approvedPantothenic acid is an ingredient in some hair and skin care products. … Williams in 1919.
Mixtures: B Plus C 300 mg, Stress B With 1000 Mg Vitamin CCategories: Vitamin B ComplexPramocaine
go.drugbank.com/drugs/DB09345ApprovedPramocaine is available by itself and in combination with other medications in various topical preparations.
Mixtures: Itch Relief Clear Skin Protectant CVS, Itch Relief Clear Skin Protectant CVSProducts: Ear Itch MD, First On Topical AnalgesicEthanol
go.drugbank.com/drugs/DB00898ApprovedInvestigationalIt is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages.
Mixtures: FIRST AID Contains 202 PIECES, Alcohol in DextroseCategories: Compounds used in a research, industrial, or household settingIndapamide
go.drugbank.com/drugs/DB00808ApprovedInvestigational[A204155] Thiazide-like diuretics such as indapamide are a valuable tool for the treatment of hypertension and continue to grow in popularity, falling behind only ACE inhibitors in terms of prescription … hypertension should include a number of lifestyle changes (ie. reduced sodium intake) along with pharmacotherapy - it should be noted that treatment with several antihypertensive agents may be required in
Mixtures: CARDIK - IN® 160/2.5, CARDIK - IN® 160/2.5Products: INDURIN 2.5 MG TABLET, 20 ADET, FLUBEST 2,5 MG FILM KAPLI TABLET, 20 ADETPertuzumab
go.drugbank.com/drugs/DB06366ApprovedInvestigationalIt was first approved by the FDA in 2012 for use with [docetaxel] and another HER2-targeted monoclonal antibody, [trastuzumab], in the treatment of metastatic HER2-positive breast cancer. … Its indicated conditions have since expanded to include use as both a neoadjuvant therapy and an adjuvant therapy in the treatment of HER2-positive breast cancers at high risk of recurrence.
Mixtures: PHESGO® 1200 MG/600 MG, PHESGO® 1200 MG/600 MGProducts: PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 600 MG/600 MG / 10 ML, PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 1200 MG/600 MG / 15 MLIndigotindisulfonic acid
go.drugbank.com/drugs/DB11577ApprovedInvestigational[A32490,A32491,A32492] In 2022, the FDA approved the intravenous use of indigotindisulfonate sodium to aid in visualizing ureter integrity in cystoscopic assessments.[L42600] … This compound is an acid-base indicator and is used in the production of food colorants and pH tests.
Categories: Compounds used in a research, industrial, or household settingProducts: INDIGO CARMINE INJECTION 20 mg/5 mlHomosalate
go.drugbank.com/drugs/DB11064ApprovedHomosalate specifically absorbs short-wave UVB rays, which are associated with DNA damage and increased risk of skin cancer. It is a common ingredient in many commercially available sunscreens. … Salicylates prevent direct skin exposure to the sun’s harmful rays by absorbing ultraviolet (UV) light.
Mixtures: Easydew EG SUN Ultra Shield, Royal Men 3-in-1 Face Moisturizer Broad Spectrum SPF 20Categories: Compounds used in a research, industrial, or household settingRamipril
go.drugbank.com/drugs/DB00178ApprovedInvestigationalIt is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. … Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular
Mixtures: Trinomia 100 mg/20 mg/5 mg Hartkapseln, Trinomia 100 mg/20 mg/10 mg HartkapselnCategories: Agents Acting on the Renin-Angiotensin SystemEtomidate
go.drugbank.com/drugs/DB00292ApprovedInvestigationalImidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Products: ETOMIDATE-LIPURO INJECTION 20 mg/10 ml, ETOMIDATE-LIPURO 20MG/10ML INJ IN 10ML GALinagliptin
go.drugbank.com/drugs/DB08882ApprovedInvestigationalLinagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated by the renal system, and obeys concentration dependant protein binding[A37050 … Linagliptin was approved by the FDA on May 2, 2011[L9557].
Mixtures: ทราเจนต้า ดูโอ 2.5/500 มก., GLYXAMBI® 25 MG/ 5 MGCategories: Drugs Used in Diabetes